Drug
Nafarelin clinical trials
- studies test it
- 5
- open now
- 2
- in phase 3
- 0
- first study started
- 2009
Keep track of what changes. Save the Nafarelin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 1
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
University of Oxford (1) · Shaare Zedek Medical Center (1) · Fundacion Dexeus (1) · Assaf-Harofeh Medical Center (1) · Insel Gruppe AG, University Hospital Bern (1)
Often tested with
Tested in the same studies.
Progesterone (3) · Utrogestan (2) · Estradiol (1) · Triptorelin (1) · Estradiol, estriol drug combination (1) · 17 alpha-Hydroxyprogesterone Caproate (1)
Studies
Open first, then newest update. How each study uses Nafarelin is read from its arms, and is right about nine times in ten.
Testing it · 5
- Intranasal Nafarelin For Triggering Oocyte MaturationRecruitingPhase 4Fundacion DexeusNCT06763926Written as Intranasal nafarelin
- Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus ProgesteroneNot yet recruitingEarly Phase 1Shaare Zedek Medical CenterNCT06870266Written as Nafarelin nasal spray
- Injection Free IVFWithdrawnPhase 2Insel Gruppe AG, University Hospital BernNCT04850261Written as Nafarelin nasal spray
- Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High RespondersStatus unknownPhase 4Assaf-Harofeh Medical CenterNCT04797338Written as Synarel, 0.2 Mg/Inh Nasal Spray
- Natural Versus HRT Cycles in Frozen Embryo Replacement TreatmentCompletedPhase 4University of OxfordNCT00843570Written as Nafarelin acetate, Oestradiol Valerate, Progesterone
Given in every arm · 1 — Nafarelin is usual care beside what is tested
Codes
What other systems call Nafarelin · ClinicalTrials.gg INT008569
- MeSH (NLM) D017274NafarelinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1X0094V6JVNAFARELINConfirmed FDA, NLM, Wikidata
- RxNorm 28656Confirmed FDA, Wikidata
- Wikidata Q3869873nafarelinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61613NafarelinConfirmed FDA, Wikidata
- DrugBank DB00666One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017274 | Nafarelin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1X0094V6JV | NAFARELIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 28656 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3869873 | nafarelin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61613 | Nafarelin | Confirmed FDA, Wikidata |
| DrugBank | DB00666 | — | One source Wikidata |
Also registered as nafarelin acetate (UNII 8ENZ0QJW4H · RxNorm 203147).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.